Presenter Institution
Aaron D. Cherniak Stockholm University
James Close Imperial College London
Jan Thomann University Hospital Basel / University of Basel
Rayyan Zafar Centre for Psychedelic research & neuropsychopharmacology, Imperial College London
Manesh Girn McGill University
Jerome Herpers KU Leuven
Joe Peill Imperial College London
Jon Sharp Beckley Foundation
Natalie Ertl Imperial College London/ Invicro
Hannah Douglass Imperial College London
Genís Ona ICEERS
Marcelo Falchi Department of Medical Psychology and Psychiatry, School of Medical Sciences, University of Campinas, Campinas, São Paulo, Brazil
Stefano J.M. van der Aalst LUMC
Isabel Wießner Department of Medical Psychology and Psychiatry, School of Medical Sciences, University of Campinas, Campinas, São Paulo, Brazil
Deborah Rudin University Hospital Basel
Federico Cavanna CONICET
Eline Pottie Ghent University
Agnieszka Sekula Swinburne University of Technology, Melbourne, Australia
Uri Shwed Ben Gurion University of the Negev
Maja Kohek University Rovira i Virgili
Benjamin Mudge Flinders University
Edriss Samani Maastricht University
Maggie Kiraga University of Maastricht
Julia Bornemann Imperial College London
Ivan Skorodumov Central Institute of Mental Health
Caterina Radu Imperial College London
Nicole Amada City University of New York, Graduate Center
Henry Whitfield Mindfulness Training Ltd
Helena D. Aicher
Psychedelic Research & Therapy Development; Department of Psychiatry, Psychotherapy and Psychosomatics; University Hospital of Psychiatry Zurich
Vito Federico Palmisano University of Groningen
Carla Pallavicini Fleni, Buenos Aires & Departamento de Fisica, Universidad de Buenos Aires
Alexandra Hempe University of Zurich / TU Dresden
Eirini Ketzitzidou Argyri University of Exeter
Alexandre Honey Oxford, Yale
Lea Julia Mertens Central Instiute of Mental Health, Department of Molecular Neuroimaging
Anne Katrin Schlag Drug Science
Alberto Cavallarin Utrecht University
Pablo Mallaroni Maastricht University
Luis Felipe Siqueira Valêncio State University of Campinas (UNICAMP)
Helle Kaasik University of Tartu
Simon Ruffell Psychae Institute, University of Melbourne
Christian B. M. Poulie University of Copenhagen
Aurora Savino Human Technopole
Anne Katrin Schlag Drug Science; Imperial College London
James Curley University of California, San Francisco
Merve Akan Central Institute of Mental Health, Mannheim
Dana Strauss University of Ottawa
Mauro Cavarra Maastricht University, Università degli Studi di Messina
Eline Haijen Maastricht University
Mikael Palner University of Southern Denmark
Jennifer Montjoy University of Arizona; Transpersonal Research Institute of Psychtherapuetic Psychedelics (TRIPP)
Carolina Seybert Champalimaud Foundation
Federico Zamberlan University of Buenos Aires
Olga Chernoloz University of Ottawa
Laura Kärtner
Department of Molecular Neuroimaging, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
Tommaso Barba Centre for Psychedelic Research, Imperial College London
Aleksandra Wingert Imperial College London
Laura Alethia de la Fuente IFIBA and INCyT
Zaskia Villa University of Arizona; Transpersonal Research Institute of Psychtherapuetic Psychedelics (TRIPP)

Ready To Attend ICPR 2022?​

Join the leading conference in Europe dedicated to advancing psychedelic research and therapies.

Want The Latest Updates?

Subscribe below to ICPR Newsletter and get all the latest updates, including discount tickets!

By clicking subscribe, I confirm to receive emails from the OPEN Foundation and agree with its privacy & terms.